NCT04384757

Brief Summary

There are more than 75% of patients with gastric cancer who are diagnosed in advanced stage in Vietnam, most of cases in T4a. The purpose of this study is to compare the technical feasibility, early and long term outcomes of open and laparoscopic distal gastrectomy for gastric adenocarcinoma in T4A stage

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P50-P75 for not_applicable gastric-cancer

Timeline
26mo left

Started Jul 2020

Longer than P75 for not_applicable gastric-cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Jul 2020Jun 2028

First Submitted

Initial submission to the registry

May 8, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 12, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

July 29, 2020

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

June 15, 2025

Status Verified

June 1, 2025

Enrollment Period

7.9 years

First QC Date

May 8, 2020

Last Update Submit

June 13, 2025

Conditions

Keywords

gastric cancerlaparoscopic gastrectomyT4a stage

Outcome Measures

Primary Outcomes (2)

  • 3 year overall survival by Kaplan Mayer

    The percentage of people in this study who are alive three years after surgery.

    3 year after surgery

  • 3 year relapse-free survival by Kaplan Mayer

    The percentage of people in this study who are alive without recurrence three years after surgery.

    3 year after surgery

Secondary Outcomes (5)

  • operative morbidity

    30 days after surgery

  • operative mortality

    30 days after surgery

  • hospital stay

    30 days after surgery

  • operative time

    intraoperative

  • Resected lymph nodes

    intraoperative

Study Arms (2)

Open distal gastrectomy

ACTIVE COMPARATOR

An incision of 15\~20 cm length is made in the abdominal midline . Standard distal gastrectomy and omentectomy will be performed with D2 lymph node dissection (around common hepatic artery, celiac artery, proximal part of splenic artery, proper hepatic artery) . As a general rule, Billroth II method was used for gastric reconstruction for most cases

Procedure: Distal gastrectomy

Laparoscopic distal gastrectomy

EXPERIMENTAL

5 trocar were used. The gastrocolic ligament was divided along the border of the transverse colon. ligating the left gastroepiploic vessels to remove group 4sb. The right gastroepiploic vein was divided and the right gastroepiploic and the inferior pyloric artery were vascularized and cut at their origin from the gastroduodenal artery, just above the pancreatic head, to dissect group 6. The dissection was continued along the hepatoduodenal ligament to removed group 5 and group 12a and along the common hepatic artery to remove group 8a and along the celiac axis to remove group 9. The left gastric vein was prepared and separately divided and then the left gastric artery was vascularized to remove group 7. The dissection was continued upward along the proximal branches of splenic vessels to remove group 11p and along the lesser curvature to remove group 1,3. As a general rule, Billroth II method was used for gastric reconstruction for most cases

Procedure: Distal gastrectomy

Interventions

Distal gastrectomy and standard D2 lymphadenectomy

Laparoscopic distal gastrectomyOpen distal gastrectomy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pathologic finding by gastric endoscopy: confirmed gastric adenocarcinoma
  • Age: 18 - 80 year old
  • Tumor located at the middle or lower third of the stomach
  • Preoperative cancer stage (CT scan stage): cT4aN0M0, cT4aN1M0, cT4aN2M0, cT4aN3M0
  • ASA score: ≤ 3
  • Informed consent patients (explanation about our clinical trials is provided to the patients or patrons, if patient is not available)

You may not qualify if:

  • Concurrent cancer or patient who was treated due to other cancer before the patient was diagnosed gastric cancer
  • Had another treatment methods, such as chemotherapy, immunotherapy, or radiotherapy
  • Pregnant patient
  • Combined resection
  • Total gastrectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center

Ho Chi Minh City, Ho Chi Minh, 700000, Vietnam

Location

Related Publications (2)

  • Dat TQ, Thong DQ, Nguyen DT, Hai NV, Phuoc TD, Anh NVT, Bac NH, Long VD. Laparoscopic vs Open Distal Gastrectomy With D2 Lymphadenectomy for Clinical T4a Gastric Cancer: The UMC-UPPERGI-01 Randomized Clinical Trial. JAMA Surg. 2026 Jan 1;161(1):9-18. doi: 10.1001/jamasurg.2025.4929.

  • Dat TQ, Thong DQ, Nguyen DT, Hai NV, Vuong NL, Bac NH, Long VD. Laparoscopic versus open distal gastrectomy with d2 lymphadenectomy in treatment of locally T4A gastric cancer: the protocol of a randomized controlled trial. BMC Surg. 2025 May 2;25(1):193. doi: 10.1186/s12893-025-02933-6.

MeSH Terms

Conditions

Stomach Neoplasms

Interventions

Gastroenterostomy

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Intervention Hierarchy (Ancestors)

Anastomosis, SurgicalSurgical Procedures, OperativeDigestive System Surgical Procedures

Study Officials

  • Long D. Vo, PhD, MD

    University Medical Center, 215 Hong Bang street, Dist. 5, HCM city, VN

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Head of GI Surgery Department

Study Record Dates

First Submitted

May 8, 2020

First Posted

May 12, 2020

Study Start

July 29, 2020

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

June 30, 2028

Last Updated

June 15, 2025

Record last verified: 2025-06

Locations